Safety Study of iCo-007 Intravitreal Injection to Treat Diabetic Macular Edema
Phase 1
Completed
- Conditions
- Diffuse Diabetic Macular Edema
- Interventions
- First Posted Date
- 2009-04-23
- Last Posted Date
- 2012-03-22
- Lead Sponsor
- iCo Therapeutics Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT00886808
- Locations
- 🇺🇸
Valley Retina Institute, McAllen, Texas, United States
🇺🇸Retina-Vitreous Associates Medical Group, Los Angeles, California, United States
🇺🇸Duke Eye Center, Durham, North Carolina, United States
© Copyright 2025. All Rights Reserved by MedPath